McGill joins Moderna in battle against global health threats
香蕉视频 has joined Moderna鈥檚 program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. McGill is the first university in Canada to join this program as it ramps up its international rollout.
鈥淭his partnership is a sign of McGill鈥檚 strength in core research that changes lives,鈥� said Martha Crago, Vice-Principal, Research & Innovation. 鈥淲e are an acknowledged leader in m香蕉视频, and joining this platform will help us develop vaccines that will protect human health everywhere on the planet.鈥�
鈥淢oderna鈥檚 goal is to create a global community of scientists who leverage our m香蕉视频 vaccine technology to develop innovative approaches to address emerging and neglected infectious diseases that pose a risk to public health,鈥� said Hamilton Bennett BSc(FSc)鈥�07, Senior Director of Vaccine Access and Partnerships, Moderna. 鈥淲e look forward to working with McGill and our other global partners to prevent future pandemics and help millions of people around the world.鈥�
The full article is available in the .